To further address the impact of timing on CD4+ T cell-mediated immunity, we adoptively transferred protective polyclonal CD44+Ly6C+CD4+ Th1EFF cells derived from chronic mice into naïve congenic recipients via intra-venous (i.v.)inoculation immediately after or four days following infection and examined protection at day 21 p.ch. This evidence concerns the gene CD44 and infection.